Display Settings:

Format

Send to:

Choose Destination

    Curr Rheumatol Rep. 2007 Aug;9(4):291-7.

    Advances in the immunobiology and treatment of inflammatory myopathies.

    Dalakas MC.

    Neuromuscular Diseases Section, US National Institute of Neurological Disorders and Stroke, US National Institutes of Health, Building 10, Room 4N248, Bethesda, MD 20892, USA. dalakasm@ninds.nih.gov

    The clinical spectrum and immunopathogenesis of inflammatory myopathies are summarized with an update on possible triggering factors, cell degeneration, and emerging new therapies.

    PMID: 17688838 [PubMed - indexed for MEDLINE]

    Supplemental Content